Readystate Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Readystate Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-507,200	Closed	-$66.9M	–	978
2025 Q1	$66.9M	Buy	+507,200	New	+$63.2M	2.23%	5
2023 Q4	–	Sell	-54,279	Closed	-$2.83M	–	725
2023 Q3	$2.83M	Buy	54,279 +779	+1%	+$45.4K	0.14%	171
2023 Q2	$3.39M	Buy	+53,500	New	+$3.33M	0.25%	101

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Readystate Asset Management's ITCI Position: Q2 2025 in Review

Readystate Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 507,200 shares — an estimated $66.9M sold.

Readystate Asset Management first reported a position in ITCI in Q2 2023 and held it in 3 quarters. The position peaked at $66.9M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Readystate Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Readystate Asset Management sold 507,200 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $66.9M.
Readystate Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2023 and held it in 3 quarters.
Readystate Asset Management's Intra-Cellular Therapies Inc. position peaked at $66.9M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.